封面
市場調查報告書
商品編碼
1983211

眼內植入市場:依植入類型、應用和地區分類

Ocular Implant Market, By Implant Type, By Application, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,眼內植入市場規模將達203.75億美元,2033年將達到330.2億美元。預計從2026年到2033年,該市場將以7.3%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 203.75億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 7.30% 2033年市場規模預測: 330.2億美元

人工水晶體是用來取代人眼天然水晶體的人工裝置。它是治療白內障手術的一部分。每隻眼睛在瞳孔後方都有一個透明的、由蛋白質構成的“晶狀體”,其中充滿液體。水晶體將光線聚焦到視網膜上,視網膜再將光線傳遞到大腦。人工植入是一種顱面假體,用於取代因眼球摘除、眼球切除或眼眶切除而缺失的天然眼球。人工植入有多種形狀,包括球形、橢圓形、現成型和客製化型。一般來說,植入可分為兩大類:非整合型(無孔)和整合型(有孔)。人工植入有助於改善眼部缺陷或失明患者的外觀。人工植入又稱為玻璃體眼或義眼。白內障是導致失明的主要原因之一,尤其是在老年人身上。然而,這些問題可以透過手術矯正,美國每年進行超過200萬例此類手術。人工水晶體(IOL)由透明塑膠製成,大小約為10美分硬幣的三分之一。目前有多種類型可供選擇。

  • 單焦點人工水晶體:這是最常見的一種。與人體內可伸縮彎曲以聚焦的天然水晶體不同,這種植入始終聚焦於一個固定距離。如果患者需要看清遠處的物體,則需要使用單焦點人工水晶體。
  • 多焦點人工水晶體:類似眼鏡中的雙焦點和漸進多焦點鏡片,這種晶體具有可以改善不同距離視力的區域。大腦可能需要幾個月的時間來適應,視力才會感覺自然。此外,與單焦點晶體相比,更容易出現光暈和光源周圍的眩光。
  • 可調式人工水晶體:此軟性水晶體的功能與人眼水晶體類似,可調整焦距,進而降低配戴老花眼鏡的可能性。
  • 散光矯正型人工水晶體:這種水晶體適用於患有散光或角膜形狀偏橢圓而非圓形的情況。散光不僅會導致近視和遠視模糊,還會影響整體視力。由於這種水晶體可以矯正散光,因此術後您可能無需配戴眼鏡來矯正散光。

市場動態

眼內植入產品數量的不斷成長,預計將推動全球眼內植入市場的成長。這些產品廣泛應用於眼科手術,用於矯正眼部畸形。例如,2019年2月,製藥公司EyePoint Pharmaceuticals, Inc.在美國推出了「YUTIQ」。 YUTIQ是一種有效期為3年的玻璃體內植入,用於治療涉及眼後部的慢性非感染性葡萄膜炎。本產品於2018年10月獲得美國食品藥物管理局(FDA)的核准。

此外,眼部功能障礙和疾病的日益普遍預計將推動全球人工眼內植入市場的成長。例如,根據青光眼研究基金會的數據,截至2019年1月,美國已有超過300萬人被診斷出患有青光眼。美國國家眼科研究所預測,到2030年,這數字將成長58%,達到420萬人。

本報告的主要特點

  • 本報告指出了各個細分市場的潛在商機,並概述了該市場中一系列有吸引力的投資提案。
  • 此外,它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
  • 本節根據以下參數介紹全球眼內植入市場的主要企業:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
  • 《全球眼內植入市場》報告面向該行業的眾多相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過分析全球眼內植入市場中使用的各種策略矩陣來促進決策。

目錄

第1章:分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機遇
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 技術進步
  • 歷史沿革
  • 企業合併(M&A)
  • 法規環境
  • 波特五力分析
  • PEST分析

第4章:全球眼內植入市場:依植入類型分類(2026-2033 年)

  • 概述
  • 人工水晶體(IOL)
  • 非球面人工水晶體
  • 散光人工水晶體
  • 多焦點人工水晶體
  • 前房型人工水晶體
  • 其他
  • 角膜植入
  • 青光眼植入
  • 眼眶植入
  • 人工眼
  • 其他

第5章:全球眼內植入市場:依應用領域分類(2026-2033年)

  • 概述
  • 青光眼手術
  • 眼部整形手術
  • 藥物輸送
  • 老齡化黃斑部病變(AMD)
  • 美容目的
  • 其他

第6章 全球眼內植入市場:按地區分類(2026-2033 年)

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第7章 競爭情勢

  • 熱圖分析
  • 公司簡介
    • Alcon(Novartis AG)
    • Pfizer Inc.
    • STAAR Surgical
    • Johnson &Johnson Services
    • MORCHER GmbH
    • Bausch &Lomb Incorporated.
    • Carl Zeiss
    • OSD Medical GmbH,
    • Ophtec BV

第8章

  • 參考
  • 分析方法
簡介目錄
Product Code: CMI2699

Ocular Implant Market is estimated to be valued at USD 20,375 Mn in 2026 and is expected to reach USD 33,020 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 20,375 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.30% 2033 Value Projection: USD 33,020 Mn

An intraocular lens implant is an artificial replacement for the lens of individual person's eye. It is part of the surgery to fix cataracts. Each eye has a lens, a window made of clear protein, and water that sits behind the pupil. The lens focuses light onto the retina, which sends it to your brain. Ocular implants are type of craniofacial prosthesis that replace an absent natural eye, following an enucleation, evisceration, or orbital exenteration. There are different types of ocular implants ranging from shape such as spherical and oval, stock, and custom. The basic simplification of implants can be to divide them into two main groups: non-integrated (non-porous) and integrated (porous). Ocular implant help to improve the appearance of people with defective eye or with lost eye. Ocular implants are also called as glass eye or artificial eye. Cataracts are a leading cause of blindness, especially in older people. But they can be corrected through surgery a procedure that is done more than 2 million times a year in the U.S. An intraocular lens implant, or IOL, is made of a clear plastic, and it is about a third the size of a dime. There are several different types.

  • Monofocal IOL: This is the most common. Unlike a person's natural lens, which can stretch or bend to help your eye focus, this implant stays focused at one fixed distance. If a person focuses at a distance.
  • Multifocal implant: Like glasses with bifocal or progressive lenses, this lens has areas that help a person see things at different distances. It could take several months for a person's brain to adapt so that a person's vision seems natural. It can sometimes cause more halos or glare around lights than a monofocal lens.
  • Accommodating IOL: This flexible option acts more like humans natural lens and focuses at more than one distance. It makes an individual less likely to need reading glasses.
  • Toric IOL: The person will get this if person have astigmatism, or a cornea that's more football-shaped than round. This can make vision blurry all over, not just close up or far away. This lens lessens astigmatism so person won't need glasses to correct it after any individual person surgery.

Market Dynamics

Increasing product launches of different types of ocular implants that are widely used in ophthalmic surgery to correct ophthalmic deformities are expected to drive the global ocular implant market growth. For instance, in February 2019, EyePoint Pharmaceuticals, Inc., Pharmaceutical company launched its YUTIQ in the U.S. YUTIQ is three-year intravitreal micro-insert for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The product was approved by U.S. Food and Drug Administration in October 2018.

Moreover, increasing prevalence of ocular dysfunction and disorder is expected to drive growth of the global ocular implant market. For instance, in January 2019, according to Glaucoma research foundation, there were over 3 million people in the U.S. that had been diagnosed with glaucoma. The National Eye Institute projects that this number will be increased by 58% and is expected to reach 4.2 million by 2030.

Key features of the study

  • This report provides an in-depth analysis of the global ocular implant market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global ocular implant market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Novartis AG, Pfizer Inc., Staar Surgical, Johnson & Johnson Services, Inc., Bausch & Lomb Incorporated., Morcher GmbH, OSD Medical GmbH, Ophtec BV, and ZEISS International
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global ocular implant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ocular implant market

Market Segmentation

  • Implant Type Insights (Revenue, USD Mn, 2026 - 2033)
    • Intraocular Lenses (IOL)
    • Aspheric IOLs
    • Toric IOLs
    • Multifocal IOLs
    • Anterior chamber IOLs
    • Others
    • Corneal Implants
    • Glaucoma Implants
    • Orbital Implants
    • Ocular prosthesis
    • Others
  • Application Insights (Revenue, USD Mn, 2026 - 2033)
    • Glaucoma Surgery
    • Oculoplasty
    • Drug Delivery
    • Age-Related Macular Degeneration (AMD)
    • Aesthetic purpose
    • Others
  • Regional Insights (Revenue, USD Mn, 2026 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Novartis AG
    • Pfizer Inc.
    • Staar Surgical
    • Johnson & Johnson Services, Inc.
    • Bausch & Lomb Incorporated.
    • Morcher GmbH
    • OSD Medical GmbH
    • Ophtec BV
    • ZEISS International

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Implant Type
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technology Advancements
  • Historical Overview
  • Merger and Acquisition
  • Regulatory Scenario
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Ocular Implant Market, By Implant Type, 2026-2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Intraocular Lenses (IOL)
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Aspheric IOLs
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Toric IOLs
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Multifocal IOL
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Anterior chamber IOL
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Others
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Corneal Implants
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Glaucoma Implants
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Orbital Implants
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Ocular prosthesis
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Others
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

5. Global Ocular Implant Market, By Application, 2026-2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Glaucoma Surgery
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Oculoplasty
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Drug Delivery
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Age-Related Macular Degeneration (AMD)
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Aesthetic purpose
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Others
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

6. Global Ocular Implant Market, By Region, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
  • North America
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Implant Type, 2026-233, (USD Mn)
    • Market Size and Forecast, By Application, 2026-233, (USD Mn)
    • Market Size and Forecast, By Country, 2026-233, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Implant Type, 2026-233, (USD Mn)
    • Market Size and Forecast, By Application, 2026-233, (USD Mn)
    • Market Size and Forecast, By Country, 2026-233, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Implant Type, 2026-233, (USD Mn)
    • Market Size and Forecast, By Application, 2026-233, (USD Mn)
    • Market Size and Forecast, By Country, 2026-233, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Implant Type, 2026-233, (USD Mn)
    • Market Size and Forecast, By Application, 2026-233, (USD Mn)
    • Market Size and Forecast, By Country, 2026-233, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Implant Type, 2026-233, (USD Mn)
    • Market Size and Forecast, By Application, 2026-233, (USD Mn)
    • Market Size and Forecast, By Country, 2026-233, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Implant Type, 2026-233, (USD Mn)
    • Market Size and Forecast, By Application, 2026-233, (USD Mn)
    • Market Size and Forecast, By Country, 2026-233, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Alcon (Novartis AG)
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • STAAR Surgical
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Johnson & Johnson Services
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • MORCHER GmbH
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Bausch & Lomb Incorporated.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Carl Zeiss
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • OSD Medical GmbH,
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Ophtec BV
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
      • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact